HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pamela W Anderson Selected Research

Protein Kinase C beta

9/2007Protein kinase C beta inhibition: the promise for treatment of diabetic nephropathy.
7/2007Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease.
11/2005The effect of ruboxistaurin on nephropathy in type 2 diabetes.
9/2003A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pamela W Anderson Research Topics

Disease

9Type 2 Diabetes Mellitus (MODY)
05/2014 - 01/2002
5Albuminuria
04/2015 - 11/2005
5Diabetic Nephropathies (Diabetic Nephropathy)
09/2007 - 09/2003
2Kidney Diseases (Kidney Disease)
08/2013 - 11/2005
2Body Weight (Weight, Body)
07/2012 - 03/2003
2Diabetes Mellitus
09/2007 - 12/2002
2Myocardial Infarction
12/2002 - 02/2002
1Peripheral Nervous System Diseases (PNS Diseases)
04/2015
1Hypoglycemia (Reactive Hypoglycemia)
05/2010
1Weight Gain
05/2010
1Fibrosis (Cirrhosis)
09/2007
1Eye Diseases (Eye Disease)
07/2007
1Chronic Renal Insufficiency
07/2007
1Hypertriglyceridemia
07/2005
1Diabetes Complications
09/2003
1Vascular System Injuries
09/2003
1Cardiovascular Diseases (Cardiovascular Disease)
03/2003
1Hypertension (High Blood Pressure)
12/2002
1Obesity
12/2002
1Osteoporosis
12/2002
1Breast Neoplasms (Breast Cancer)
12/2002
1Acute Coronary Syndrome
12/2002
1Unstable Angina
02/2002
1Ischemia
02/2002
1Stroke (Strokes)
02/2002
1Transient Ischemic Attack
02/2002
1Insulin Resistance
01/2002

Drug/Important Bio-Agent (IBA)

5ruboxistaurinIBA
04/2015 - 11/2005
4Protein Kinase C betaIBA
09/2007 - 09/2003
4Raloxifene Hydrochloride (Evista)FDA Link
07/2005 - 01/2002
4Selective Estrogen Receptor Modulators (SERM)IBA
07/2005 - 01/2002
3Exenatide (Byetta)FDA Link
05/2014 - 07/2012
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
07/2012 - 05/2010
2LipidsIBA
07/2012 - 01/2002
2Insulin (Novolin)FDA Link
05/2010 - 01/2002
2Transforming Growth Factor beta (TGF-beta)IBA
09/2007 - 04/2007
2AlbuminsIBA
09/2007 - 11/2005
2CreatinineIBA
07/2007 - 11/2005
2Estrogens (Estrogen)FDA Link
07/2005 - 12/2002
1Insulin Glargine (Lantus)FDA Link
05/2014
1Glucagon-Like Peptide-1 ReceptorIBA
07/2012
1Glucose (Dextrose)FDA LinkGeneric
07/2012
1Insulin Lispro (Humalog)FDA Link
05/2010
1Hypoglycemic Agents (Hypoglycemics)IBA
05/2010
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2007
1Angiotensin Receptor AntagonistsIBA
09/2007
1Fibric Acids (Fibrates)IBA
07/2005
1Triglycerides (Triacylglycerol)IBA
07/2005
1Apolipoprotein A-I (Apolipoprotein A1)IBA
03/2003
1Apolipoproteins B (ApoB)IBA
03/2003
1oxidized low density lipoproteinIBA
03/2003
1Fibrinogen (Factor I)FDA Link
03/2003
1LDL CholesterolIBA
12/2002
1Oral ContraceptivesIBA
12/2002
1Biomarkers (Surrogate Marker)IBA
01/2002
1Blood Glucose (Blood Sugar)IBA
01/2002
1Hemoglobin AIBA
01/2002
1Hormones (Hormone)IBA
01/2002

Therapy/Procedure

6Therapeutics
07/2012 - 02/2002
3Glycemic Control
07/2012 - 01/2002
1Cardiac Rehabilitation
12/2002